DK1608336T3 - Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler - Google Patents

Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler

Info

Publication number
DK1608336T3
DK1608336T3 DK04757846T DK04757846T DK1608336T3 DK 1608336 T3 DK1608336 T3 DK 1608336T3 DK 04757846 T DK04757846 T DK 04757846T DK 04757846 T DK04757846 T DK 04757846T DK 1608336 T3 DK1608336 T3 DK 1608336T3
Authority
DK
Denmark
Prior art keywords
formulation
hydrofluoracanes
propellants
dosing inhaler
inhaler
Prior art date
Application number
DK04757846T
Other languages
Danish (da)
English (en)
Inventor
George Destefano
Linda Jean Kelash-Cannavo
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1608336T3 publication Critical patent/DK1608336T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK04757846T 2003-03-20 2004-03-19 Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler DK1608336T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20
PCT/US2004/008375 WO2004084858A2 (en) 2003-03-20 2004-03-19 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants

Publications (1)

Publication Number Publication Date
DK1608336T3 true DK1608336T3 (da) 2008-06-02

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04757846T DK1608336T3 (da) 2003-03-20 2004-03-19 Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler

Country Status (28)

Country Link
US (1) US7914770B2 (enExample)
EP (1) EP1608336B1 (enExample)
JP (1) JP4708332B2 (enExample)
KR (1) KR101113003B1 (enExample)
CN (1) CN1761455A (enExample)
AT (1) ATE390125T1 (enExample)
AU (1) AU2004224367B2 (enExample)
BR (1) BRPI0408547A (enExample)
CA (1) CA2519523C (enExample)
CO (1) CO5640070A2 (enExample)
CY (1) CY1108137T1 (enExample)
DE (1) DE602004012718T2 (enExample)
DK (1) DK1608336T3 (enExample)
EA (1) EA009087B1 (enExample)
EC (1) ECSP056029A (enExample)
ES (1) ES2304616T3 (enExample)
HR (1) HRP20050822B1 (enExample)
ME (1) ME00420B (enExample)
MX (1) MXPA05009920A (enExample)
NO (1) NO336457B1 (enExample)
NZ (1) NZ542957A (enExample)
PL (1) PL1608336T3 (enExample)
PT (1) PT1608336E (enExample)
RS (1) RS51663B (enExample)
SI (1) SI1608336T1 (enExample)
UA (1) UA89751C2 (enExample)
WO (1) WO2004084858A2 (enExample)
ZA (1) ZA200506463B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
EA013428B1 (ru) * 2004-07-02 2010-04-30 Бёрингер Ингельхайм Интернациональ Гмбх РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
EP2187969A2 (en) * 2007-08-17 2010-05-26 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
CN102686260B (zh) 2009-11-25 2014-10-01 贝林格尔.英格海姆国际有限公司 喷雾器
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
MX380824B (es) 2014-05-07 2025-03-12 Boehringer Ingelheim Int Nebulizador y recipiente.
PL3139984T3 (pl) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizator
US20180071231A1 (en) * 2015-04-10 2018-03-15 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2021216779A1 (en) * 2020-04-21 2021-10-28 Amphastar Pharmaceuticals, Inc. Anti-viral pharmaceutical formulations administered via devices for lung targeted delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
DE69701051T2 (de) 1993-04-30 2000-08-31 Minnesota Mining And Mfg. Co., Saint Paul Abdichtung an Aerosolbehältern
ES2119219T5 (es) 1993-07-15 2011-05-11 Minnesota Mining And Manufacturing Company Cierres estancos para uso en un dispositivo para suministrar un aerosol.
GEP20002266B (en) * 1995-04-14 2000-10-25 Glaxo Wellcome Inc Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
DE59904648D1 (de) * 1998-08-04 2003-04-24 Jago Res Ag Muttenz Medizinische aerosolformulierungen
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
CA2452140C (en) 2001-06-26 2010-12-14 Norton Healthcare, Ltd. An improved aerosol actuator

Also Published As

Publication number Publication date
JP4708332B2 (ja) 2011-06-22
PL1608336T3 (pl) 2008-09-30
PT1608336E (pt) 2008-04-21
ME00420B (me) 2011-12-20
DE602004012718T2 (de) 2009-05-07
KR101113003B1 (ko) 2012-02-24
JP2006520797A (ja) 2006-09-14
AU2004224367A1 (en) 2004-10-07
ATE390125T1 (de) 2008-04-15
BRPI0408547A (pt) 2006-03-07
ES2304616T3 (es) 2008-10-16
NZ542957A (en) 2008-09-26
CA2519523A1 (en) 2004-10-07
US20040184994A1 (en) 2004-09-23
DE602004012718D1 (de) 2008-05-08
EA200501363A1 (ru) 2006-04-28
HRP20050822A2 (en) 2006-10-31
EA009087B1 (ru) 2007-10-26
SI1608336T1 (sl) 2008-08-31
ECSP056029A (es) 2006-01-27
ZA200506463B (en) 2006-04-26
WO2004084858A2 (en) 2004-10-07
AU2004224367B2 (en) 2009-10-08
MXPA05009920A (es) 2005-11-04
RS51663B (sr) 2011-10-31
WO2004084858A3 (en) 2004-11-04
US7914770B2 (en) 2011-03-29
CA2519523C (en) 2012-03-13
UA89751C2 (ru) 2010-03-10
EP1608336B1 (en) 2008-03-26
HRP20050822B1 (hr) 2013-09-30
CO5640070A2 (es) 2006-05-31
RS20050705A (sr) 2008-04-04
CN1761455A (zh) 2006-04-19
CY1108137T1 (el) 2014-02-12
KR20050111382A (ko) 2005-11-24
EP1608336A2 (en) 2005-12-28
NO336457B1 (no) 2015-08-31
NO20054839L (no) 2005-10-19

Similar Documents

Publication Publication Date Title
DK1608336T3 (da) Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
BRPI0412320A (pt) uso de um agente modificador de reologia, e composições de revestimento
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
EA200700042A1 (ru) РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
AR034298A1 (es) Una valvula dosificadora para un inhalador de dosis dosificada que mejora el flujo de la formulacion a la camara dosificadora
BRPI0512988A (pt) método para aumentar a meia-vida plasmática de uma molécula, composto, uso do mesmo, e, composição farmacêutica
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
SE0301653D0 (sv) Novel compounds
BRPI0412310A (pt) uso de um agente controlador de reologia, agente modificador de reologia, concentrados, e, composições com reologia melhorada
NO20072005L (no) Nye heterocykliske amider
DK1583756T3 (da) Thiophencarboxamider som inhibitorer af enzymet IKK-2
NO20052557L (no) Morfolinderivater for bruk som dopamin-agonister i behandling av blant annet seksuell dysfunksjon.
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
EA200501698A1 (ru) Противовспенивающие композиции
TW200744612A (en) New combination
DE602004013011D1 (de) Haarbehandlungszusammensetzungen
ES2194744T3 (es) Derivados de quinocardina, su procedimiento de preparacion y su aplicacion como antifungicos.
CR8162A (es) Piridinylanilides
ECSP056231A (es) Fluorbutenos nematicidas que contienen tiazolina
WO2006089954A3 (en) Compounds for stabilizing factor vii polypeptide formulations
DE60324816D1 (de) Impfstoffe gegen allergien
ATE400618T1 (de) Pulver-überzugsmittelzusammensetzung
SE0702711L (sv) Ny kemisk substans lämplig för användning som mjukgörare i sprängämnes- och drivmedelsblandningar